PHARMAID logo

Pharmaids Pharmaceuticals Ltd

PHARMAID·BSE·
31.10 -0.88 (-2.75%)
Market Cap109.54 Cr
PE Ratio
Volume5,842
Day High - Low32.28 - 30.67
52W High-Low53.90 - 25.60
DocStoX Score
1.9/10
Poor
Fair Value
Sign in to see
ROE
-26.50%
Weak
P/E
Debt / Equity
0.49
Moderate
Industry
Healthcare
Pharmaceuticals
Overall View
Poor

Price performance

Day30.67
32.28
52W25.60
53.90
DocStoX take

Supported by valuation (6.0), but held back by quality (0.3). Scored on 4 of 5 measures.

DocStoX score

Low confidence
1.9
/10
Poor
Quality
Weak
ROE -26.5%
Valuation
Fair
P/B 2.4× on assets (no earnings to value)
Growth
No data
No multi-year history
Risk
Moderate
D/E 0.49
Momentum
Weak
19% of 52-week range

Scored on 4 of 5 measures — the rest have no data for this company.

At a glance

Market Cap
₹110 Cr
52W High / Low
₹54 / ₹26
Dividend Yield
0.00%
Promoter Holding
32.99%
EPS (TTM)
₹-3.06
Book Value
₹13.51

Key highlights

  • Loss-making in some of the last 5 years
  • Quality is weak (0.3/10)
0 Positives4 Watchouts

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Healthcare stocks · Pharmaceuticals

Pharmaids Pharmaceuticals Ltd peers in Healthcare

Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.